T0	Participants 0 25	Endometrial cytodiagnosis
T1	Participants 147 191	cytological screening for endometrial cancer
T2	Participants 443 620	315 women (premenopause 251, postmenopause 64) were randomly assigned to two groups who underwent the endometrial cytological screening with either the softcyte or the endocyte.
T3	Participants 1073 1106	screening for endometrial cancer.